Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes.
Saved in:
| Title: | Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes. |
|---|---|
| Authors: | Purvis GSD; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Collino M; Department of Drug Science and Technology, University of Turin, Turin, Italy., Loiola RA; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Baragetti A; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy., Chiazza F; Department of Drug Science and Technology, University of Turin, Turin, Italy., Brovelli M; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy.; Centro SISA per lo studio del'Aterosclerosi, Bassini Hospital, Lombardy, Italy., Sheikh MH; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Collotta D; Department of Drug Science and Technology, University of Turin, Turin, Italy., Cento A; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Mastrocola R; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Aragno M; Department of Molecular Biotechnology and Sciences for the Health, University of Turin, Turin, Italy., Cutrin JC; Department of Molecular Biotechnology and Sciences for the Health, University of Turin, Turin, Italy., Reutelingsperger C; Department of Biochemistry, Cardiovascular Research Institute, Maastricht University, Maastricht, Netherlands., Grigore L; Centro SISA per lo studio del'Aterosclerosi, Bassini Hospital, Lombardy, Italy.; IRCCS Multimedica, Lombardy, Italy., Catapano AL; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy., Yaqoob MM; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Norata GD; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy.; Centro SISA per lo studio del'Aterosclerosi, Bassini Hospital, Lombardy, Italy., Solito E; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli 'Federico II', Naples, Italy., Thiemermann C; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2019 Mar 27; Vol. 10, pp. 571. Date of Electronic Publication: 2019 Mar 27 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
